Back to search

Virginia Commonwealth University

AUGMENTING GUADECITABINE TO PROMOTE ANTICANCER IMMUNITY IN MURINE BREAST CANCER

Abstract

dc:description.abstract

In immune-competent individuals, tumor growth occurs due to a failure of the immune system to recognize and destroy malignant cells. Immune surveillance can be curtailed by the presence of immunosuppressive cells such as myeloid-derived suppressor cells (MDSCs) and T-regulatory cells (Tregs) which both serve to dampen antitumor immunity. These studies utilize a metronomic low-dose therapeutic approach to examine the effects of anticancer drugs against murine breast cancer and the effects on the immune cell compartments. The focus of these studies revolve around the drug guadecitabine (guad), a second-generation DNA methyl-transferase inhibitor (DNMTi). DNMTi’s have been shown to dysregulate the methylation state responsible for gene silencing, which leads to an upregulation of many silenced genes including cancer associated antigens. Guad was initially combined with intratumoral injections of CpG oligodeoxynucleotides, which serve as a danger signal and initiates an immune response against antigens within the treated tumor. Dual treatment of CpG and guad showed decreased tumor burden in treated animals when compared to vehicle controls. Next, guad was combined with low doses of cyclophosphamide (cyp) which is a chemotherapy that has been shown to selectively deplete Tregs at low doses. This drug combination resulted in a depletion in splenic and tumor MDSCs and Tregs, increased CD8+ T cell function, increased tumor associated antigen expression, as well as reduction in tumor size in murine 4T1 and E0771 breast cancer models.

Degree

thesis:*
Name thesis:degree_name
Doctor of Philosophy
Level thesis:degree_level
Dissertation
Discipline thesis:degree_discipline
Microbiology & Immunology

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Smith, Timothy M, Jr.
  • https://orcid.org/0000-0001-6445-4149
Contributors dc:contributor
  • Rebecca Martin
  • Harry Bear
  • Shawn Wang
  • Huiping Zhou
  • Kimberly Jefferson

Subjects

dc:subject × 9

Rights

dc:rights
Statement dc:rights
  • © Timothy M. Smith Jr.

Identifiers

dc:identifier.*

Chain of custody

source
Harvested from
Virginia Commonwealth University
Base URL
scholarscompass.vcu.edu/do/oai/
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
related terms
citation

Smith, Timothy M, Jr.; https://orcid.org/0000-0001-6445-4149. AUGMENTING GUADECITABINE TO PROMOTE ANTICANCER IMMUNITY IN MURINE BREAST CANCER. Dissertation thesis, https://doi.org/10.25772/4T6X-J148